Acute liver failure risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(5 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Acute liver failure}}
{{Acute liver failure}}
{{CMG}} {{AE}}
{{CMG}} {{AE}} {{HS}}
 
{{PleaseHelp}}
 
==Overview==
==Overview==
Certain conditions can put a person at risk for developing acute liver failure. These include having certain [[infections]], [[vascular disorders]], autoimmune conditions, [[metabolic diseases]], and primary cancers or [[malignancies]].
The risk factors in the development of acute liver failure can be categorized into [[viral]], [[drugs]] and [[toxins]], [[vascular]], [[metabolic]] and systemic illnesses. Common risk factors of acute liver failure include [[acetaminophen toxicity]], [[viral hepatitis]] (most commonly [[hepatitis A]], [[hepatitis B]] and [[hepatitis E]]), [[alcoholic hepatitis]], [[autoimmune hepatitis]], [[sepsis]], [[heart failure]], [[renal failure]], [[Immunocompromised|immunocompromised state]], older age and [[malnourishment]]. [[Acetaminophen toxicity]] is the most common risk factor of acute liver failure in the developed world and [[viral hepatitis]] (most commonly [[hepatitis A]], [[hepatitis B]] and [[hepatitis E]]) is most common in the developing world.
 
==Risk Factors==
==Risk Factors==
Risk factors in the development of acute liver failure include:
Risk factors in the development of acute liver failure include:<ref name="pmid18825677">{{cite journal| author=Ichai P, Samuel D| title=Etiology and prognosis of fulminant hepatitis in adults. | journal=Liver Transpl | year= 2008 | volume= 14 Suppl 2 | issue=  | pages= S67-79 | pmid=18825677 | doi=10.1002/lt.21612 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18825677  }} </ref><ref name="pmid12484709">{{cite journal |vauthors=Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM |title=Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States |journal=Ann. Intern. Med. |volume=137 |issue=12 |pages=947–54 |year=2002 |pmid=12484709 |doi= |url=}}</ref><ref name="pmid23013075">{{cite journal| author=Hoofnagle JH, Nelson KE, Purcell RH| title=Hepatitis E. | journal=N Engl J Med | year= 2012 | volume= 367 | issue= 13 | pages= 1237-44 | pmid=23013075 | doi=10.1056/NEJMra1204512 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23013075  }} </ref><ref name="pmid16775039">{{cite journal| author=Wasley A, Fiore A, Bell BP| title=Hepatitis A in the era of vaccination. | journal=Epidemiol Rev | year= 2006 | volume= 28 | issue=  | pages= 101-11 | pmid=16775039 | doi=10.1093/epirev/mxj012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16775039  }} </ref><ref name="pmid12484709">{{cite journal |vauthors=Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM |title=Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States |journal=Ann. Intern. Med. |volume=137 |issue=12 |pages=947–54 |year=2002 |pmid=12484709 |doi= |url=}}</ref><ref name="pmid16025496">{{cite journal| author=Björnsson E, Olsson R| title=Outcome and prognostic markers in severe drug-induced liver disease. | journal=Hepatology | year= 2005 | volume= 42 | issue= 2 | pages= 481-9 | pmid=16025496 | doi=10.1002/hep.20800 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16025496  }} </ref>
*Drug-related [[hepatotoxicity]] and [[idiosyncratic]] drug reactions are the most common risk factor in the developed world. The most common drug causing hepatotoxicity is [[acetaminophen]].
*Drug-related [[hepatotoxicity]] and [[idiosyncratic drug reactions]] are the most common risk factor in the developed world. The most common drug causing [[hepatotoxicity]] is [[acetaminophen]].
*[[Viral hepatitis]] is the most common risk factor of acute liver failure in the developing world.
*[[Viral hepatitis]] is the most common risk factor of acute liver failure in the developing world.
:*[[Hepatitis A virus]], [[Hepatitis B virus]], [[Hepatitis D virus]], or [[Hepatitis E virus]].
**[[Hepatitis A virus]], [[Hepatitis B virus]], [[Hepatitis D virus]], or [[Hepatitis E virus]].
:*Other [[atypical viruses]] causing [[viral hepatitis]] and [[fulminant hepatic failure]], include [[cytomegalovirus]], [[hemorrhagic fever virus]]es, [[herpes simplex virus]], [[paramyxovirus]] and [[Epstein-Barr virus]].
**Other [[atypical viruses]] causing [[viral hepatitis]] and [[fulminant hepatic failure]] include [[cytomegalovirus]], [[hemorrhagic fever virus]]es, [[herpes simplex virus]], [[paramyxovirus]] and [[Epstein-Barr virus]].
*Old age
*Old age
*[[Malnourishment]]
*[[Malnourishment]]
*[[Vascular diseases]]
*[[Vascular diseases]]
:*[[Ischemic hepatitis]]  
**[[Ischemic hepatitis]]  
:*[[Hepatic vein thrombosis]] ([[Budd-Chiari syndrome]])
**[[Hepatic vein thrombosis]] ([[Budd-Chiari syndrome]])
:*[[Hepatic veno-occlusive]] disease
**Hepatic [[veno-occlusive disease]]
:*[[Portal vein thrombosis]]
**[[Portal vein thrombosis]]
*[[Autoimmune disease]]
*[[Autoimmune disease]]
:*[[Autoimmune hepatitis]]
**[[Autoimmune hepatitis]]
*[[Metabolic diseases]]
*[[Metabolic diseases]]
:*[[Acute fatty liver of pregnancy]]
**[[Acute fatty liver of pregnancy]]
:*[[Alpha-1 antitrypsin deficiency]]
**[[Alpha-1 antitrypsin deficiency]]
:*[[Reye syndrome]]
**[[Reye syndrome]]
:*[[Tyrosinemia]]
**[[Tyrosinemia]]
:*[[HELLP syndrome]]
**[[HELLP syndrome]]
*[[Malignancy]]
*[[Malignancy]]
:*[[Primary liver tumor]]: [[Hepatocellular carcinoma]]
**[[Primary liver tumor]]: [[Hepatocellular carcinoma]]
:*[[Secondary liver tumor]]: Extensive hepatic metastases or infiltration from [[breast cancer]], [[lung cancer]], [[melanoma]], [[lymphoma]], [[leukemia]].
**[[Secondary liver tumor]]: Extensive hepatic [[metastases]] or infiltration from [[breast cancer]], [[lung cancer]], [[melanoma]], [[lymphoma]], [[leukemia]].
*Long-term lcohol consumption
*[[Long-term effects of alcohol|Long-term alcohol consumption]]
*[[Immunocompromised state]]
*[[Immunocompromised host|Immunocompromised state]]
*[[Other systemic diseases]]
*Other systemic diseases
**[[Sepsis]]
**[[Sepsis]]
**[[Cardiac failure]]
**[[Cardiac failure]]
**[[Respiratory failure]]
**[[Respiratory failure]]
**[[Renal failure]]
**[[Renal failure]]
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Hepatology]]
[[Category:Hepatology]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]

Latest revision as of 19:41, 18 December 2017

Acute liver failure Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute Liver Failure from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute liver failure risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute liver failure risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute liver failure risk factors

CDC on Acute liver failure risk factors

Acute liver failure risk factors in the news

Blogs on Acute liver failure risk factors

Directions to Hospitals Treating Acute liver failure

Risk calculators and risk factors for Acute liver failure risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Husnain Shaukat, M.D [2]

Overview

The risk factors in the development of acute liver failure can be categorized into viral, drugs and toxins, vascular, metabolic and systemic illnesses. Common risk factors of acute liver failure include acetaminophen toxicity, viral hepatitis (most commonly hepatitis A, hepatitis B and hepatitis E), alcoholic hepatitis, autoimmune hepatitis, sepsis, heart failure, renal failure, immunocompromised state, older age and malnourishment. Acetaminophen toxicity is the most common risk factor of acute liver failure in the developed world and viral hepatitis (most commonly hepatitis A, hepatitis B and hepatitis E) is most common in the developing world.

Risk Factors

Risk factors in the development of acute liver failure include:[1][2][3][4][2][5]

References

  1. Ichai P, Samuel D (2008). "Etiology and prognosis of fulminant hepatitis in adults". Liver Transpl. 14 Suppl 2: S67–79. doi:10.1002/lt.21612. PMID 18825677.
  2. 2.0 2.1 Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM (2002). "Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States". Ann. Intern. Med. 137 (12): 947–54. PMID 12484709.
  3. Hoofnagle JH, Nelson KE, Purcell RH (2012). "Hepatitis E." N Engl J Med. 367 (13): 1237–44. doi:10.1056/NEJMra1204512. PMID 23013075.
  4. Wasley A, Fiore A, Bell BP (2006). "Hepatitis A in the era of vaccination". Epidemiol Rev. 28: 101–11. doi:10.1093/epirev/mxj012. PMID 16775039.
  5. Björnsson E, Olsson R (2005). "Outcome and prognostic markers in severe drug-induced liver disease". Hepatology. 42 (2): 481–9. doi:10.1002/hep.20800. PMID 16025496.

Template:WH Template:WS